フェムテックの世界市場：2025年～2033年

フェムテックの世界市場は、2024年には389億米ドルに達し、2033年までには1,123億米ドルに達すると予測され、予測期間中の2025年から2033年のCAGRは12.6%で成長する見込みです。

フェムテックはヘルスケアにおける変革的なセクターであり、革新的なソリューションを通じて女性特有の健康ニーズに対応することに焦点を当てています。診断ツール、ウェアラブル、遠隔医療プラットフォーム、妊産婦の健康、月経の健康、骨盤と性の健康、不妊症、更年期障害、避妊など、女性特有の症状に特化したモバイルアプリケーションなど、さまざまな製品やサービスが含まれます。

さらに、フェムテックは、骨粗鬆症や心血管疾患など、女性に不釣り合いに影響する一般的な健康問題にも対応しています。

市場力学：

促進要因と抑制要因

技術進歩の高まり

技術の進歩がフェムテック市場を大きく牽引しています。ウェアラブル・ヘルス・トラッカー、不妊治療モニター、月経健康機器など、最先端の新製品が頻繁に発売されることが、市場拡大にさらに拍車をかけています。こうした進歩は、フェムテックソリューションの精度と機能性を向上させるだけでなく、消費者の信頼と採用率を高め、市場の継続的な成長に貢献しています。例えば、2023年12月、Arva Healthは女性向けの家庭用不妊検査を発売しました。この検査は、女性のホルモンのモニタリングと追跡を支援し、生殖に関する健康について十分な情報に基づいた選択ができるようにするものです。

ハイテク企業、ヘルスケアプロバイダー、新興企業間のコラボレーションはイノベーションを加速させ、女性の健康に合わせたより高度でユーザーフレンドリーな機器の開発を可能にしています。例えば、Bayerは2024年10月、プレシジョンケアの革新的なディープテックの新興企業であるImpliとパートナーシップを締結しました。この提携は、初期段階の研究を進めると同時に、ホルモンモニタリングの様々な使用事例の可能性を調査し、ImpliにBayerのグローバルイノベーションエコシステムへのアクセスを提供することを目的としています。このように、上記の要因は市場の成長を促進すると予想されます。

高い生産コスト

高度なフェムテックデバイスに関連する高コストは、潜在的な消費者の大部分にとってのアクセシビリティを制限することにより、フェムテック市場の妨げになると予想されます。多くのフェムテックソリューション、特にウェアラブルデバイスや特殊な健康デバイスは高価であるため、特に新興市場や低所得者層では、すべてのユーザーが購入できる価格ではない可能性があります。この価格障壁は、消費者が明確で直接的なメリットがないこれらの製品への投資をためらう可能性があるため、普及率を鈍らせる可能性があります。さらに、コストが高いため、ヘルスケアプロバイダーや保険会社がこれらのソリューションを広く提供する能力が制限され、市場の成長がさらに制限される可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 技術の進歩の高まり
  • 抑制要因
    • 高い生産コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 タイプ別

• デバイス
• ソフトウェア
• サービス
• その他

第7章 用途別

• 女性のメンタルヘルスと幸福
• 生殖に関する健康
• 老年女性の健康
• 腫瘍学
• その他

第8章 エンドユーザー別

• 病院
• 診断センター
• 不妊治療センター
• がんセンター
• 在宅医療
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Chiaro Technology Ltd.
  • 会社概要
  • 製品ポートフォリオ
    • 製品説明
    • 製品の主要業績評価指標（KPI）
    • 過去および予測の製品販売
    • 製品販売量
  • 財務概要
    • 会社の収益
    • 地域別収益分配
    • 収益予測
  • 主な発展
    • 合併と買収
    • 主な製品開発活動
    • 規制当局の承認等
  • SWOT分析
• HeraMED
• Flo Health Inc.
• Allara Health
• Bloomlife
• Syrona Health
• Joylux, Inc.
• Coroflo Ltd.
• Bonzun
• Natural Cycles USA Corp
• Athena Feminine Technologies, Inc.
  • パイプライン製品の説明
  • 製品の主要業績評価指標（KPI）
  • 主な活動
  • 市場参入のタイムライン
  • 製品普及率
  • 売上予測と予測
• Herbo Nutra
• Orchid Lifesciences
• Indo-World
• Aushadhi Herbal
• 各市場参入企業に対しても同様のデータが提供されます。

第12章 付録

The global femtech market reached US$ 38.90 billion in 2024 and is expected to reach US$ 112.30 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

FemTech is a transformative sector within healthcare that focuses on addressing women's unique health needs through innovative solutions. It encompasses various products and services, including diagnostic tools, wearables, telemedicine platforms, and mobile applications that cater specifically to female-specific conditions such as maternal health, menstrual health, pelvic and sexual health, fertility, menopause, and contraception.

Moreover, FemTech also addresses general health issues that disproportionately affect women, such as osteoporosis and cardiovascular diseases.

Market Dynamics: Drivers & Restraints

Rising Technological Advancements

Rising technological advancements are significantly driving the femtech market. The frequent launch of new, cutting-edge products, such as wearable health trackers, fertility monitors, and menstrual health devices, is further fueling market expansion. These advancements not only improve the accuracy and functionality of femtech solutions but also increase consumer trust and adoption, contributing to the continued growth of the market. For instance, in December 2023, Arva Health launched home fertility tests for women. This test helps women monitor and track their hormones, thus empowering them to make informed choices about their reproductive health.

Collaborations between tech companies, healthcare providers, and startups are accelerating innovation and enabling the development of more advanced, user-friendly devices tailored to women's health. For instance, in October 2024, Bayer entered into a partnership with Impli, an innovative, deep-tech start-up in precision care. The partnership is intended to advance early-stage research while exploring a variety of potential use cases for hormone monitoring and providing Impli with access to Bayer's global innovation ecosystem. Thus, the above factors are expected to drive the market growth.

High production costs

High costs associated with advanced femtech devices are expected to hinder the femtech market by limiting accessibility for a large segment of potential consumers. As many femtech solutions, particularly wearables and specialized health devices can be expensive, they may not be affordable for all users, especially in emerging markets or among lower-income populations. This price barrier can slow down adoption rates, as consumers may be hesitant to invest in these products without clear, immediate benefits. Additionally, the high costs may limit the ability of healthcare providers and insurers to offer these solutions widely, further restricting the market growth.

Segment Analysis

The global femtech market is segmented based on type, application, end-user, and region.

Type:

Devices segment is expected to dominate the global femtech market share

The devices segment is expected to dominate the femtech market due to the rising demand for innovative health monitoring tools tailored to women's needs. Additionally, advances in wearable technology, such as fertility trackers, pregnancy monitoring devices, and menstrual health gadgets, are driving the segment's growth. Several companies and organizations are introducing advanced devices to track and monitor women's health conditions. For instance, in June 2024, Noise launched new women's health tracking features for its smart ring, Luna. This update aims to offer personalized menstrual health insights and predictions, helping women with various menstrual patterns better understand their health.

As consumers are increasingly seeking personalized, at-home healthcare solutions, the convenience and accessibility of these devices are creating more demand for these devices. Companies are collaborating to introduce advanced devices that help individuals track their health and to incorporate advanced features in the existing devices. For instance, in February 2023, Samsung Electronics and Natural Cycles entered into a partnership to bring advanced temperature-based menstrual cycle tracking capabilities to the Galaxy Watch5 series. Furthermore, continuous technological improvements in device accuracy, user experience, and integration with digital health platforms are expected to further strengthen the dominance of the devices segment in the femtech market.

Geographical Analysis

North America is expected to hold a significant position in the global femtech market share

North America holds a major portion of the femtech market and is expected to dominate the market during the forecast period. This is due to consumers' growing adoption of femtech products and services. The rising adoption and significant investment in both healthcare and technology are additional factors contributing to the region's market growth.

Companies are introducing the latest and most advanced solutions with the growing demand and supporting women's health. For instance, in December 2024, ConTIPI Medical and EVERSANA announced the U.S. commercial launch of ProVate, a new non-surgical device for women experiencing pelvic organ prolapse (POP). It is a ready-to-use, disposable device for patients' at-home use, and is now available for physicians across the U.S. to prescribe

The region's advanced healthcare infrastructure, along with a focus on women's health, supports the rapid growth of femtech innovations. Additionally, increasing R&D funding from both private and public sectors is accelerating the development of advanced solutions tailored to the needs of women, positioning North America in the dominant position.

Competitive Landscape

The major global players in the femtech market include Chiaro Technology Ltd., HeraMED, Flo Health Inc., Allara Health, Bloomlife, Syrona Health, Joylux, Inc., Coroflo Ltd., Bonzun, and Natural Cycles USA Corp among others.

Key Developments

• In November 2024, PatientsLikeMe (PLM) launched Ella, an AI assistant to help women manage their health, powered by the generative AI platform Ema.
• 30 May 2024 - UNFPA, the United Nations Sexual and Reproductive Health Agency, launched a groundbreaking initiative to help organizations enhance their employees' reproductive health using the world's first sexual and reproductive health ESG indicators.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Femtech Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. High production costs
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Devices*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Software
• 6.4. Services
• 6.5. Others

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Women's Mental Health and Well-being*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Reproductive Health
• 7.4. Women's Geriatric Health
• 7.5. Oncology
• 7.6. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Diagnostic Centers
• 8.4. Fertility Centers
• 8.5. Cancer Centers
• 8.6. Home Care
• 8.7. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

• 11.1. Chiaro Technology Ltd.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals etc.
  • 11.1.5. SWOT Analysis
• 11.2. HeraMED
• 11.3. Flo Health Inc.
• 11.4. Allara Health
• 11.5. Bloomlife
• 11.6. Syrona Health
• 11.7. Joylux, Inc.
• 11.8. Coroflo Ltd.
• 11.9. Bonzun
• 11.10. Natural Cycles USA Corp
  *Similar data will be provided for each market player.

Emerging Market Players

• 11.11. Athena Feminine Technologies, Inc.
  • 11.11.1. Pipeline Products Description
  • 11.11.2. Product Key Performance Indicators (KPIs)
  • 11.11.3. Key Activities
  • 11.11.4. Market Entry Timelines
  • 11.11.5. Product Penetration Rate
  • 11.11.6. Sales Estimation and Projections
• 11.12. Herbo Nutra
• 11.13. Orchid Lifesciences
• 11.14. Indo-World
• 11.15. Aushadhi Herbal
  *Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us